Tags: Chemical Compound, Chemical Substance.

Zibotentan (ZD4054) is an anti-cancer candidate. It is an endothelin receptor antagonist.It failed a phase III clinical trial for prostate cancer but other trials are planned. Tolerability of zibotentan plus docetaxel has been evaluated.

Loading...

This page contains content from the copyrighted Wikipedia article "Zibotentan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.